# Predicting and Preventing Adverse Maternal and Child Outcomes of Opioid Use Disorder in Pregnancy

> **NCT05942313** · — · RECRUITING · sponsor: **Ilana Hull** · enrollment: 100 (estimated)

## Conditions studied

- Opioid Use Disorder
- Pregnancy Related

## Interventions

- **DRUG:** Buprenorphine/ Methadone exposure

## Key facts

- **NCT ID:** NCT05942313
- **Lead sponsor:** Ilana Hull
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-28
- **Primary completion:** 2026-12-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-03-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05942313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05942313, "Predicting and Preventing Adverse Maternal and Child Outcomes of Opioid Use Disorder in Pregnancy". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05942313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*